GlassScriptPhysician profile
Annie Thury
NPI 1639617731
$280.71
in general payments reported to CMS, 2019-2025
10 companies · $54.60 in 2025
The $54.60 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.99 · 2023: $50.43 · 2024: $155 · 2025: $54.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192 · Education: $67.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $191.77 |
| Education | $67.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $83.27 | 2024 | Veozah |
| Viatris Specialty LLC | $38.84 | 2025 | Yupelri |
| Pfizer INC. | $33.99 | 2023 | |
| Amgen INC. | $21.99 | 2024 | Prolia, Evenity |
| Biogen, INC. | $20.99 | 2021 | |
| Mylan Specialty L.P. | $18.23 | 2024 | Yupelri |
| Lilly USA, LLC | $16.44 | 2023 | Mounjaro |
| Novartis Pharmaceuticals Corporation | $16.23 | 2024 | |
| Abbvie INC. | $15.76 | 2025 | |
| Novo Nordisk INC | $14.97 | 2024 | Ozempic, Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annie Thury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.